Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., . . . Lee, H. J. (2019). ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study. Haematologica.
Chicago Style CitationStrati, Paolo, et al. "ABVD Plus Rituximab Versus ABVD Alone for Advanced Stage, High-risk Classical Hodgkin Lymphoma: A Randomized Phase 2 Study." Haematologica 2019.
MLA CitationStrati, Paolo, et al. "ABVD Plus Rituximab Versus ABVD Alone for Advanced Stage, High-risk Classical Hodgkin Lymphoma: A Randomized Phase 2 Study." Haematologica 2019.
Warning: These citations may not always be 100% accurate.